Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial
Authors:
Open Access
- 9 January 2007
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 10 (2) , 155-159
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasiaBJU International, 2005
- Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension StudyEuropean Urology, 2002
- AlfuzosinDrugs, 2002
- One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaireUrology, 2000
- Efficacy and Safety of a New Prolonged Release Formulation of Alfuzosin 10 mg Once Daily versus Alfuzosin 2.5 mg Thrice Daily and Placebo in Patients with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2000
- A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic ObstructionEuropean Urology, 1999
- Efficacy and Safety of Sustained- Release Alfuzosin 5 mg in Patients with Benign Prostatic HyperplasiaEuropean Urology, 1997
- Patient Reactions to a Program Designed to Facilitate Patient Participation in Treatment Decisions for Benign Prostatic HyperplasiaMedical Care, 1995
- The American Urological Association Symptom Index for Benign Prostatic HyperplasiaJournal of Urology, 1992
- Characterisation of Human Prostatic Adrenoceptors using Pharmacology Receptor Binding and LocalisationBritish Journal of Urology, 1989